ACCUM-002
LIVE

Serial Number

98154157

Owner

Defence Therapeutics Inc.

Attorney

Bradley L. Cohn

Filing Date

Aug 28, 2023

Add to watchlist:

No watchlists yet
View on USPTO

ACCUM-002 Trademark

Serial Number: 98154157

ACCUM-002 is a trademark filed by Defence Therapeutics Inc. on August 28, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Defence Therapeutics Inc. (13 trademarks)

1680-200 Burrard St

Entity Type: 03

Trademark Details

Filing Date

August 28, 2023

Registration Date

Not Registered

Goods & Services

Drug delivery agents consisting of intracellular enhancers in the nature of compounds that facilitate delivery of a wide range of pharmaceuticals; medicinal preparations for use in oncology; pharmaceutical antibody preparations for the treatment of cancer; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories; vaccines for human use; all of the foregoing excluding smallpox vaccines and treatments for smallpox

Antibody testing, namely, antibody profiling for scientific research purposes; research and development of vaccines and medicines; scientific research for medical purposes in the field of oncology; all of the foregoing excluding research and development relating to smallpox vaccines and treatments for smallpox

Filing History

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
May 21, 2026 GNS2
INQUIRY TO SUSPENSION E-MAILED
May 21, 2026 GNSI
SUSPENSION INQUIRY WRITTEN
May 21, 2026 CNSI
ASSIGNED TO EXAMINER
Oct 9, 2025 DOCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Aug 30, 2025 RCSC
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 12, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 12, 2025 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Aug 12, 2025 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 22, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
May 22, 2025 GNSL
SUSPENSION LETTER WRITTEN
May 22, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
May 21, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 21, 2025 CRFA
ASSIGNED TO LIE
May 20, 2025 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
May 6, 2025 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Mar 18, 2025 GNS2
INQUIRY TO SUSPENSION E-MAILED
Mar 18, 2025 GNSI
SUSPENSION INQUIRY WRITTEN
Mar 18, 2025 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Mar 17, 2025 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 19, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Aug 19, 2024 GNSL
SUSPENSION LETTER WRITTEN
Aug 19, 2024 CNSL
ASSIGNED TO EXAMINER
Aug 16, 2024 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 28, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 28, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 28, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 25, 2024 GNRN
NON-FINAL ACTION E-MAILED
Apr 25, 2024 GNRT
NON-FINAL ACTION WRITTEN
Apr 25, 2024 CNRT
ASSIGNED TO EXAMINER
Apr 23, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 26, 2023 NWOS
NEW APPLICATION ENTERED
Aug 31, 2023 NWAP